FDA Adverse Event Injury Summary report: N

FLEXTEND II

MDR report key: 2173099 · Received July 23, 2011

Report

Report Number
2124215-2011-10403
Event Type
Injury
Date Received
July 23, 2011
Date of Event
June 9, 2011
Report Date
June 15, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS LEAD WILL BE RETURNED TO BOSTON SCIENTIFIC FOR ANALYSIS. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED, OR UPON COMPLETION OF ANALYSIS.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT DURING A ROUTINE FOLLOW-UP SHORTLY AFTER IMPLANT, ABNORMAL IMPEDANCE MEASUREMENTS AND LOSS OF CAPTURE WERE NOTED ON THIS RIGHT VENTRICULAR LEAD DUE TO DISLODGEMENT. A REVISION PROCEDURE WAS DONE AND THIS LEAD WAS REPOSITIONED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FLEXTEND II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4097

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention